SCHEMBL997788

SCHEMBL997788

COC(=O)c1n[nH]c2cc(C(F)F)cc(Cc3ccc(Cl)cc3Cl)c12

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 1/20 0.39
MAP2K4 P45985 1/20 0.38
P2RX7 Q99572 1/20 0.38
GSK3B P49841 1/20 0.38
GAA P10253 2/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
S1PR4 O95977 1/20 0.37
KDM4E B2RXH2 1/20 0.37
STAT3 P40763 1/20 0.37
HIF1A Q16665 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL998544 0.83 KDM4E (0.45) ALPLNPSR1HPGDMAP2K4P2RX7
SCHEMBL998780 0.75 KDM4E (0.43) MAP2K4GSK3BSMN1; SMN2KDM4ESTAT3
SCHEMBL997498 0.75 KDM4E (0.43) NPSR1HPGDMAP2K4P2RX7ALDH1A1
SCHEMBL5023203 0.69 TBXA2R (0.45) ALPLNPSR1P2RX7GSK3BHIF1A
SCHEMBL27956837 0.69 KDM4E (0.58) MAP2K4ALDH1A1SMN1; SMN2KDM4ESTAT3
SCHEMBL30609861 0.67 MAP2K4 (0.65) ALPLMAP2K4GSK3BSMN1; SMN2KDM4E
SCHEMBL4791992 0.67 MAP2K4 (0.65) ALPLMAP2K4GSK3BSMN1; SMN2KDM4E
SCHEMBL4793264 0.67 KDM4E (0.63) ALPLHPGDMAP2K4ALDH1A1SMN1; SMN2
SCHEMBL4109673 0.67 CYP1A2 (0.53) NPSR1ALDH1A1SMN1; SMN2HIF1ACYP3A4
SCHEMBL5267750 0.66 NR2E1 (0.37) NPSR1HPGDP2RX7GSK3BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed
EP-2451783-A2 LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT University Of Kansas (US) 2012-05-16 EP disclosed
WO-2011005759-A2 LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT UNIVERSITY OF KANSAS (US) 2011-01-13 WO disclosed